相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients
Masaomi Nangaku et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis
Animut Alebel et al.
BMC INFECTIOUS DISEASES (2021)
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome *
Abolghasem Allahyari et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis
Marjon E. A. Wormgoor et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Oxford-AstraZeneca COVID-19 vaccine efficacy
Maria Deloria Knoll et al.
LANCET (2021)
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Giacomo Lanzoni et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial
Masoud Nouri-Vaskeh et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
Charles D. Bengtson et al.
FRONTIERS IN MEDICINE (2021)
COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Rebecca Forman et al.
HEALTH POLICY (2021)
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
Dipayan Chaudhuri et al.
INTENSIVE CARE MEDICINE (2021)
A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
Mandana Pouladzadeh et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
Chong-xiang Chen et al.
LEUKEMIA (2021)
An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
Alvaro Rea-Neto et al.
SCIENTIFIC REPORTS (2021)
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
Sultan A. M. Saghir et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2021)
Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Rizaldy Taslim Pinzon et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes
William Bain et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
Michael A. Puskarich et al.
ECLINICALMEDICINE (2021)
Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Shaolei Ma et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
Lei Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
HPTLC analysis of Fumaria parviflora (Lam.) methanolic extract of whole plant
Anjali Bhargava et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Pathogenesis guided therapeutic management of COVID-19: an immunological perspective
Ashutosh Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Fengxiang Song et al.
RADIOLOGY (2020)
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection
Francesca Colavita et al.
ANNALS OF INTERNAL MEDICINE (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
David M. G. Halpin et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesus Villar et al.
LANCET RESPIRATORY MEDICINE (2020)
A Review of Coronavirus Disease-2019 (COVID-19)
Tanu Singhal
INDIAN JOURNAL OF PEDIATRICS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Convalescent Plasma to Treat COVID-19 Possibilities and Challenges
John D. Roback et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Management of COVID-19 Respiratory Distress
John J. Marini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
Dan Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anti-IL6R role in treatment of COVID-19-related ARDS
Franco Maria Buonaguro et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
Jun Kobayashi et al.
ANNALS OF INTENSIVE CARE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient
Emily Hillaker et al.
PHARMACOTHERAPY (2020)
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population
Manuel A. Torres Acosta et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
Shahd Horie et al.
INTENSIVE CARE MEDICINE (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta -analysis
Yong Hu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
Saeed K. Alzghari et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
Enrico Capochiani et al.
FRONTIERS IN MEDICINE (2020)
Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports
Brandon Michael Henry et al.
JOURNAL OF CRITICAL CARE (2020)
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Hunter B. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2020)
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
Andreas Neubauer et al.
LEUKEMIA (2020)
Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells A case report
Bing Liang et al.
MEDICINE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
Jonathan Rilinger et al.
TRIALS (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study
Olena Bolotova et al.
PLOS ONE (2020)
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
Alejandro Piscoya et al.
PLOS ONE (2020)
Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
Yukihiro Shimizu
WORLD JOURNAL OF CLINICAL CASES (2020)
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
Judith van Paassen et al.
CRITICAL CARE (2020)
Pirfenidone: A novel hypothetical treatment for COVID-19
Soroush Seifirad
MEDICAL HYPOTHESES (2020)
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition
Hidenori Takahashi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm
Mozhgan Jahani et al.
JOURNAL OF INFLAMMATION-LONDON (2020)
Acute respiratory distress syndrome in COVID-19
Nahid Dadashzadeh et al.
IMMUNOPATHOLOGIA PERSA (2020)
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey
Susan J. Tzotzos et al.
CRITICAL CARE (2020)
Acute respiratory failure in COVID-19: is it typical ARDS?
Xu Li et al.
CRITICAL CARE (2020)
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
Beth Russell et al.
ECANCERMEDICALSCIENCE (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study
Ziyun Shao et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Late i.v. steroid treatment for severe COVID-19-induced acute respiratory distress syndrome: a case report
Yasuaki Kumakawa et al.
ACUTE MEDICINE & SURGERY (2020)
High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series
Clara So et al.
RESPIROLOGY CASE REPORTS (2020)
Acute respiratory distress syndrome
Michael A. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Insights into the immuno-pathogenesis of acute respiratory distress syndrome
Judith Ju Ming Wong et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
HIV screening in men and women in Senegal: coverage and associated factors; analysis of the 2017 demographic and health survey
Ndeye Aissatou Lakhe et al.
BMC INFECTIOUS DISEASES (2019)
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
Cong Liu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy
Kyung-Yil Lee
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Inhibition of CD8+ T cells and elimination of myeloid cells by CD4+ Foxp3- T regulatory type 1 cells in acute respiratory distress syndrome
Guang-Gang Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo
Michael C. W. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Common Immunopathogenesis Mechanism for Infectious Diseases: The Protein-Homeostasis-System Hypothesis
Kyung-Yil Lee
INFECTION AND CHEMOTHERAPY (2015)
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
Yiwu Yan et al.
CELL RESEARCH (2013)
Sympathetic ophthalmia: a review of literature
Nemaly Chaithanyaa et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2012)
Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: A need for early immune-modulators for severe cases
Kyung-Yil Lee et al.
MEDICAL HYPOTHESES (2011)
Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis
Sachin Sud et al.
INTENSIVE CARE MEDICINE (2010)
Lung pathology of fatal severe acute respiratory syndrome
JM Nicholls et al.
LANCET (2003)
The pragmatics of prone positioning
E Messerole et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
分享论文
